Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromfenac vs betamethasone eye drops for diabetic macular edema
jRCTs031180308Completed
- Sponsor
- Senju Pharmaceutical Co., Ltd.
- Start
- Jun 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised trial in diabetic macular edema (DME) comparing Bromfenac 0.1% ophthalmic solution with Betamethasone 0.1% ophthalmic/otic/nasal solution (2 arms). Started Jun 2017; status: completed.
02
Drugs
bromfenac sodiumbetamethasone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on jRCTs031180308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180308.